Apyx Medical Corporation

Last updated September 27, 2026

Organization details

Legal name
Apyx Medical Corporation
Former names
Bovie Medical Corp An CON Genetics Inc
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
3841 — Surgical & Medical Instruments & Apparatus
Jurisdiction of incorporation
Delaware
Headquarters city
Clearwater
Headquarters state / province
Florida
Headquarters country
United States
Fiscal year end
December
Ticker symbol
APYX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0000719135
EIN
11-2644611

Board of directors

Chief executives

Charles D. Goodwin II · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of August 6, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

3 of this board's directors also sit on 4 other boards. 2 are in the same sector.

Network of Apyx Medical Corporation's board connections CVD Equipment Corporation CVD Equipment Corporat... Comtech Telecommunications Corp. Comtech Telecommunicat... Lantheus Holdings Inc. Lantheus Holdings Inc. Xtant Medical Holdings Inc. Xtant Medical Holdings... Lawrence Waldman Lawrence Waldman Minnie Baylor-Henry Minnie Baylor-Henry Stavros G. Vizirgianakis Stavros G. Vizirgian... Apyx Medical Corporation
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Jun 30, 2026 Lawrence Waldman Director Option exercise +12,000 $1.88 $22,560
Jun 30, 2026 Lawrence Waldman Director Shares withheld for tax −5,024 $4.49 $22,558
Jun 15, 2026 Roman Shawn David Officer (Chief Operating Officer) Option exercise +15,000 $3.23 $48,450
Jun 15, 2026 Roman Shawn David Officer (Chief Operating Officer) Shares withheld for tax −10,533 $4.60 $48,452
Jun 11, 2026 Stavros G. Vizirgianakis Director Grant or award +450,000 — —
Mar 15, 2026 CITRONOWICZ MOSHE Officer (Senior Vice President) Option exercise +37,000 $1.80 $66,600
Jan 27, 2026 Roman Shawn David Officer (Chief Operating Officer) Option exercise +12,000 $1.80 $21,600
Aug 13, 2024 HILL MATTHEW C Officer (Chief Financial Officer) Open-market purchase +5,336 $1.13 $6,030
Dec 12, 2023 HILL MATTHEW C Officer (Chief Financial Officer) Open-market purchase +2,500 $2.19 $5,475
Nov 14, 2023 Charles D. Goodwin II Director, Officer (Chief Executive Officer) Open-market purchase +50,000 $1.57 $78,500
Jul 12, 2023 Lawrence Waldman Director Option exercise +5,338 $2.97 $15,854
Jun 26, 2023 Hornsby Todd Officer (Executive Vice President) Option exercise +15,000 $1.77 $26,550
Jun 26, 2023 Hornsby Todd Officer (Executive Vice President) Open-market sale −15,000 $7.56 $113,400
Jun 6, 2023 Michael Geraghty Director Option exercise +10,000 $2.79 $27,900
Jan 7, 2022 Craig A. Swandal Director Option exercise +7,173 $9.42 $67,570

Organizations in the same sector, closest in location and size first.

Questions about Apyx Medical Corporation

Who is the CEO of Apyx Medical Corporation?

Charles D. Goodwin II is Apyx Medical Corporation's Chief Executive Officer.

How many directors are on Apyx Medical Corporation's board?

Apyx Medical Corporation's board has 9 directors: Andrew Makrides, Charles D. Goodwin II, Craig A. Swandal, John C. Andres, Lawrence Waldman, Michael Geraghty, Minnie Baylor-Henry, Stavros G. Vizirgianakis and Wendy Lauren Levine.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="apyx-medical-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.